Basic Information
| RNALocate ID: | RLID:11002466 |
| RNA Symbol: | hsa-miR-376c-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-376c-3p |
| RNA ID: | miRBase:MIMAT0000720 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002028 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11002464 | Exosome | Serum | 18589210 |
| RLID:11002465 | Exosome | Brain tissue | 23382797 |
| RLID:11002467 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000410 | Microvesicle | Fibroblasts|Mesenchymal stem cells|Urine | |
| RLID-D:11001198 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-376c-3p | Splenic marginal zone lymphoma | MNDR-E-MI-46176 |
| MNDR | hsa-miR-376c-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-46177 |
| MNDR | hsa-miR-376c-3p | Oral squamous cell carcinoma | MNDR-E-MI-46178 |
| MNDR | hsa-miR-376c-3p | Medulloblastoma | MNDR-E-MI-46179 |
| MNDR | hsa-miR-376c-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-46180 |
| MNDR | hsa-miR-376c-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-46181 |
| MNDR | hsa-miR-376c-3p | Lymphoma | MNDR-E-MI-46182 |
| MNDR | hsa-miR-376c-3p | Lymphoma non-hodgkin | MNDR-E-MI-46183 |
| MNDR | hsa-miR-376c-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-46184 |
| MNDR | hsa-miR-376c-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-46185 |
| MNDR | hsa-miR-376c-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-46186 |
| MNDR | hsa-miR-376c-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-46187 |
| MNDR | hsa-miR-376c-3p | Her2-receptor positive breast cancer | MNDR-E-MI-46188 |
| MNDR | hsa-miR-376c-3p | Breast cancer luminal | MNDR-E-MI-46189 |
| MNDR | hsa-miR-376c-3p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-46190 |
| MNDR | hsa-miR-376c-3p | Dermatomyositis | MNDR-E-MI-46191 |
| MNDR | hsa-miR-376c-3p | Prostate cancer | MNDR-E-MI-46192 |
| MNDR | hsa-miR-376c-3p | Gastric cancer | MNDR-E-MI-46193 |
| MNDR | hsa-miR-376c-3p | Gastric lymphoma | MNDR-E-MI-46194 |
| MNDR | hsa-miR-376c-3p | Alzheimer disease | MNDR-E-MI-46195 |
| MNDR | hsa-miR-376c-3p | Bladder cancer | MNDR-E-MI-46196 |
| MNDR | hsa-miR-376c-3p | Dysautonomia familial | MNDR-E-MI-46197 |
| MNDR | hsa-miR-376c-3p | Distal muscular dystrophy | MNDR-E-MI-46198 |
| MNDR | hsa-miR-376c-3p | Duchenne muscular dystrophy | MNDR-E-MI-46199 |
| MNDR | hsa-miR-376c-3p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-46200 |
| MNDR | hsa-miR-376c-3p | Head and neck cancer | MNDR-E-MI-46201 |
| MNDR | hsa-miR-376c-3p | Cardiovascular disease | MNDR-E-MI-46202 |
| MNDR | hsa-miR-376c-3p | Parkinson disease | MNDR-E-MI-46203 |
| MNDR | hsa-miR-376c-3p | Basal-like breast cancer | MNDR-E-MI-46204 |
| MNDR | hsa-miR-376c-3p | Thyroid cancer | MNDR-E-MI-46205 |
| MNDR | hsa-miR-376c-3p | Pituitary neoplasms | MNDR-E-MI-46206 |
| MNDR | hsa-miR-376c-3p | Pancreatic cancer | MNDR-E-MI-46207 |
| MNDR | hsa-miR-376c-3p | Melanoma | MNDR-E-MI-46208 |
| MNDR | hsa-miR-376c-3p | Colon cancer | MNDR-E-MI-46209 |
| MNDR | hsa-miR-376c-3p | Colon adenocarcinoma | MNDR-E-MI-46210 |
| MNDR | hsa-miR-376c-3p | Ovarian cancer | MNDR-E-MI-46211 |
| MNDR | hsa-miR-376c-3p | Prostate adenocarcinoma | MNDR-E-MI-46212 |
| MNDR | hsa-miR-376c-3p | Carcinoma ductal breast | MNDR-E-MI-46213 |
| MNDR | hsa-miR-376c-3p | Glioblastoma | MNDR-E-MI-46214 |
| MNDR | hsa-miR-376c-3p | Glioma | MNDR-E-MI-46215 |
| MNDR | hsa-miR-376c-3p | Nemaline myopathy | MNDR-E-MI-46216 |
| MNDR | hsa-miR-376c-3p | Epilepsy temporal lobe | MNDR-E-MI-46217 |
| MNDR | hsa-miR-376c-3p | Osteosarcoma | MNDR-E-MI-46218 |
| MNDR | hsa-miR-376c-3p | Breast carcinoma | MNDR-E-MI-46219 |
| MNDR | hsa-miR-376c-3p | Meningioma | MNDR-E-MI-46220 |
| MNDR | hsa-miR-376c-3p | Gastric adenocarcinoma | MNDR-E-MI-46221 |
| MNDR | hsa-miR-376c-3p | Cervical squamous cell carcinoma | MNDR-E-MI-46222 |
| MNDR | hsa-miR-376c-3p | Bone-invasive pituitary adenoma | MNDR-E-MI-46223 |
| MNDR | hsa-miR-376c-3p | Lung adenocarcinoma | MNDR-E-MI-46224 |
| MNDR | hsa-miR-376c-3p | Adrenocortical cancer | MNDR-E-MI-46225 |
| MNDR | hsa-miR-376c-3p | Thyroid carcinoma | MNDR-E-MI-46226 |
| MNDR | hsa-miR-376c-3p | Ovarian carcinoma | MNDR-E-MI-46227 |
| MNDR | hsa-miR-376c-3p | Bladder urothelial carcinoma | MNDR-E-MI-46228 |
| MNDR | hsa-miR-376c-3p | Pancreatic adenocarcinoma | MNDR-E-MI-46229 |
| MNDR | hsa-miR-376c-3p | Carcinoma renal cell | MNDR-E-MI-46230 |
| MNDR | hsa-miR-376c-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-46231 |
| MNDR | hsa-miR-376c-3p | Renal clear cell carcinoma | MNDR-E-MI-46232 |
| MNDR | hsa-miR-376c-3p | Cholangiocarcinoma | MNDR-E-MI-46233 |
| MNDR | hsa-miR-376c-3p | Esophageal cancer | MNDR-E-MI-46234 |
| MNDR | hsa-miR-376c-3p | Lung small cell carcinoma | MNDR-E-MI-46235 |
| MNDR | hsa-miR-376c-3p | Synovial sarcoma | MNDR-E-MI-46236 |
| MNDR | hsa-miR-376c-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-46237 |
| MNDR | hsa-miR-376c-3p | Breast invasive carcinoma | MNDR-E-MI-46238 |
| MNDR | hsa-miR-376c-3p | Hepatocellular carcinoma | MNDR-E-MI-46239 |
| MNDR | hsa-miR-376c-3p | B-cell lymphoma | MNDR-E-MI-46240 |
| MNDR | hsa-miR-376c-3p | Rheumatoid arthritis | MNDR-E-MI-46241 |
| MNDR | hsa-miR-376c-3p | T-cell leukemia | MNDR-E-MI-46242 |
| MNDR | hsa-miR-376c-3p | Barrett's adenocarcinoma | MNDR-E-MI-46243 |
| MNDR | hsa-miR-376c-3p | Hodgkin lymphoma | MNDR-E-MI-46244 |
| MNDR | hsa-miR-376c-3p | Burkitt lymphoma | MNDR-E-MI-46245 |
| MNDR | hsa-miR-376c-3p | Crohn disease | MNDR-E-MI-46246 |
| MNDR | hsa-miR-376c-3p | Tonsil cancer | MNDR-E-MI-46247 |
| MNDR | hsa-miR-376c-3p | Colorectal cancer | MNDR-E-MI-46248 |
| MNDR | hsa-miR-376c-3p | Multiple myeloma | MNDR-E-MI-46249 |
| MNDR | hsa-miR-376c-3p | Ovarian epithelial cancer | MNDR-E-MI-46250 |
| MNDR | hsa-miR-376c-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-46251 |
| MNDR | hsa-miR-376c-3p | Stroke lacunar | MNDR-E-MI-46252 |
| MNDR | hsa-miR-376c-3p | Barrett's carcinogenesis | MNDR-E-MI-46253 |
| MNDR | hsa-miR-376c-3p | Breast cancer her3+ negative | MNDR-E-MI-46254 |
| MNDR | hsa-miR-376c-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-46255 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACVR1C | Homo sapiens | RR00039085 |
TOP